Development of the Cu/ZIF-8 MOF Acid-Sensitive Nanocatalytic Platform Capable of Chemo/Chemodynamic Therapy with Improved Anti-Tumor Efficacy

Jie Liang,Weiwei Zhang,Jun Wang,Wanzhen Li,Fei Ge,Weihao Jin,Yugui Tao

DOI: https://doi.org/10.1021/acsomega.3c00269

IF: 4.1

2023-05-26

ACS Omega

Abstract:<p> </p> <p>Recently, the combinationof chemotherapy and chemodynamictherapy(CDT) has become a desirable strategy in the treatment of cancer.However, a satisfactory therapeutic outcome is often difficult toachieve due to the deficiency of endogenous H₂O₂ and O₂ in the tumor microenvironment. In this study,a CaO₂@DOX@Cu/ZIF-8 nanocomposite was prepared as a novelnanocatalytic platform to enable the combination of chemotherapy andCDT in cancer cells. The anticancer drug doxorubicin hydrochloride(DOX) was loaded onto calcium peroxide (CaO₂) nanoparticles(NPs) to form CaO₂@DOX, which was then encapsulated ina copper zeolitic imidazole ester MOF (Cu/ZIF-8) to form CaO₂@DOX@Cu/ZIF-8 NPs. In the mildly acidic tumor microenvironment, CaO₂@DOX@Cu/ZIF-8 NPs rapidly disintegrated, releasing CaO₂, which reacted with water to generate H₂O₂ and O₂ in the tumor microenvironment. The abilityof CaO₂@DOX@Cu/ZIF-8 NPs to combine chemotherapy and CDTwas assessed by conducting cytotoxicity, living dead staining, cellularuptakes, H&amp;E staining, and TUNEL assays in vitro and in vivo.The combination of chemotherapy and CDT of CaO₂@DOX@Cu/ZIF-8NPs had a more favorable tumor suppression effect than the nanomaterialprecursors, which were not capable of the combined chemotherapy/CDT.</p>

chemistry, multidisciplinary